Precision Radionuclide Therapies for Prostate Cancer and Neuroendocrine Tumors

Radionuclide therapy prostate cancer neuroendocrine tumors Memorial Şişli Hospital

Memorial Şişli Hospital provides advanced theranostic treatments including Lu-177 PSMA, Ac-225 PSMA, Ra-223, and Lu-177 DOTATATE for prostate cancer and neuroendocrine tumors, aligned with European safety and quality standards.Photo: Memorial Şişli Hospital via FL Comms.

Format

PNG

Source

Memorial Health Group

Téléchargements